Mesenchymal stem cells (MSCs) are promising tools for cell-based therapies due to their
homing to injury sites, where they secrete bioactive factors such as cytokines, lipids, and …

During the last two decades, mesenchymal stem cells (MSCs) gained a place of privilege in
the field of regenerative medicine. Recently, extracellular vesicles (EVs) have been …

In regenerative medicine related to orthopedic conditions, mesenchymal stromal cells
(MSCs) and their extracellular vesicles (EVs) have been proposed as innovative clinical …

Background Mesenchymal stromal cell (MSC)-enriched products showed positive clinical
outcomes in regenerative medicine, where tissue restoration and inflammation control are …

Mesenchymal stem cells (MSCs) derived from adipose tissue and used either as expanded
cells or minimally manipulated cell preparations showed positive clinical outcomes in …

Osteoarthritis (OA) is a degenerative joint disorder characterized by the progressive
deterioration of articular cartilage driven and sustained by catabolic and inflammatory …

The study of the miRNA cargo embedded in extracellular vesicles (EVs) released from
adipose-derived mesenchymal stromal cells (ASC) preconditioned with IL-1β, an …

Aim: Mesenchymal stromal cells (MSCs) emerged as a promising therapeutic option for
osteoarthritis (OA) management, in particular those isolated from adipose tissue (hASCs) …

Cartilage cells (CCs), adipose tissue (ASC)-and bone marrow (BMSC)-derived
mesenchymal stromal cells (MSCs) have been shown as promising candidates for the …

Secretome derived from mesenchymal stem cells (MSCs) have profound effects on tissue
regeneration, which could become the basis of future MSCs therapies. Hypoxia, as the …